论文部分内容阅读
目的 寻找治疗中晚期肝癌安全、可靠、有效的方法。方法 采用双介入治疗 ,即经股动脉插管超选择肝动脉灌注和栓塞 (THACE) ,同期行B超或CT引导下经皮穿刺瘤体内注射无水洒精 (PEIT) ,治疗失去手术机会的中晚期肝癌 2 9例。结果 随访 3～ 2 4个月。死亡 9例 ,12例存活 3～ 10个月 ,7例存活 10～ 2 4个月 ,1例已超过 2年。本组未出现明显并发症。结论 双介入治疗中晚期肝癌能有效地延长病人生存期 ,提高病人生存质量 ,是中晚期肝癌综合治疗中一种有效可行的方法
Objective To find a safe, reliable and effective method for the treatment of advanced liver cancer. Methods A double interventional therapy was used to percutaneous transhepatic arterial perfusion and embolization (THACE). In the same period, percutaneous needle puncture of PEIT was performed under the guidance of B-ultrasound or CT. The treatment lost the opportunity of surgery In advanced liver cancer 29 cases. The results were followed up for 3 ~ 24 months. 9 died, 12 survived 3 to 10 months, 7 survived 10 to 24 months and 1 had been over 2 years. This group did not appear significant complications. Conclusion Double interventional treatment of advanced hepatocellular carcinoma can effectively prolong the survival of patients and improve the quality of life of patients, is an effective and feasible method for the comprehensive treatment of advanced hepatocellular carcinoma